healthcarereimagined

Envisioning healthcare for the 21st century

  • About
  • Economics

An early guide to policymaking on generative AI – MIT Technology Review

Posted by timmreardon on 04/08/2023
Posted in: Uncategorized.


How lawmakers are thinking about the risks of the latest tech revolution

By Tate Ryan-Mosley And March 27, 2023

This article is from The Technocrat, MIT Technology Review’s weekly tech policy newsletter about power, politics, and Silicon Valley. To receive it in your inbox every Friday, sign up here.

Earlier this week, I was chatting with a policy professor in Washington, DC, who told me that students and colleagues alike are asking about GPT-4 and generative AI: What should they be reading? How much attention should they be paying?

She wanted to know if I had any suggestions, and asked what I thought all the new advances meant for lawmakers. I’ve spent a few days thinking, reading, and chatting with the experts about this, and my answer morphed into this newsletter. So here goes!

Though GPT-4 is the standard bearer, it’s just one of many high-profile generative AI releases in the past few months: Google, Nvidia, Adobe, and Baidu have all announced their own projects. In short, generative AI is the thing that everyone is talking about. And though the tech is not new, its policy implications are months if not years from being understood. 

GPT-4, released by OpenAI last week, is a multimodal large language model that uses deep learning to predict words in a sentence. It generates remarkably fluent text, and it can respond to images as well as word-based prompts. For paying customers, GPT-4 will now power ChatGPT, which has already been incorporated into commercial applications. 

The newest iteration has made a major splash, and Bill Gates called it “revolutionary” in a letter this week. However, OpenAI has also been criticized for a lack of transparency about how the model was trained and evaluated for bias. 

Despite all the excitement, generative AI comes with significant risks. The models are trained on the toxic repository that is the internet, which means they often produce racist and sexist output. They also regularly make things up and state them with convincing confidence. That could be a nightmare from a misinformation standpoint and could make scams more persuasive and prolific. 

Generative AI tools are also potential threats to people’s security and privacy, and they have little regard for copyright laws. Companies using generative AI that has stolen the work of others are already being sued.

Alex Engler, a fellow in governance studies at the Brookings Institution, has considered how policymakers should be thinking about this and sees two main types of risks: harms from malicious use and harms from commercial use. Malicious uses of the technology, like disinformation, automated hate speech, and scamming, “have a lot in common with content moderation,” Engler said in an email to me, “and the best way to tackle these risks is likely platform governance.” (If you want to learn more about this, I’d recommend listening to this week’s Sunday Show from Tech Policy Press, where Justin Hendrix, an editor and a lecturer on tech, media, and democracy, talks with a panel of experts about whether generative AI systems should be regulated similarly to search and recommendation algorithms. Hint: Section 230.)  

Policy discussions about generative AI have so far focused on that second category: risks from commercial use of the technology, like coding or advertising. So far, the US government has taken small but notable actions, primarily through the Federal Trade Commission (FTC). The FTC issued a warning statement to companies last month urging them not to make claims about technical capabilities that they can’t substantiate, such as overstating what AI can do. This week, on its business blog, it used even stronger language about risks companies should consider when using generative AI.

“If you develop or offer a synthetic media or generative AI product, consider at the design stage and thereafter the reasonably foreseeable—and often obvious—ways it could be misused for fraud or cause other harm. Then ask yourself whether such risks are high enough that you shouldn’t offer the product at all,” the blog post reads. 

The US Copyright Office also launched a new initiative intended to deal with the thorny policy questions around AI, attribution, and intellectual property. 

The EU, meanwhile, is sticking true to its reputation as the world leader in tech policy. At the start of this year my colleague Melissa Heikkilä wrote about the EU’s efforts to try to pass the AI Act. It’s a set of rules that would prevent companies from releasing models into the wild without disclosing their inner workings, which is precisely what some critics are accusing OpenAI of with the GPT-4 release. 

The EU intends to separate high-risk uses of AI, like hiring, legal, or financial applications, from lower-risk uses like video games and spam filters, and require more transparency around the more sensitive uses. OpenAI has acknowledged some of the concerns about the speed of adoption. In fact, its own CEO, Sam Altman, told ABC News he shares many of the same fears. However, the company is still not disclosing key data about GPT-4. 

For policy folks in Washington, Brussels, London, and offices everywhere else in the world, it’s important to understand that generative AI is here to stay. Yes, there’s significant hype, but the recent advances in AI are as real and important as the risks that they pose. 

What I am reading this week

Yesterday, the United States Congress called Shou Zi Chew, the CEO of TikTok, to a hearing about privacy and security concerns raised by the popular social media app. His appearance came after the Biden administration threatened a national ban if its parent company, ByteDance, didn’t sell off the majority of its shares. 

There were lots of headlines, most using a temporal pun, and the hearing laid bare the depths of the new technological cold war between the US and China. For many watching, the hearing was both important and disappointing, with some legislators displaying poor technical understanding and hypocrisy about how Chinese companies handle privacy when American companies collect and trade data in much the same ways. 

It also revealed how deeply American lawmakers distrust Chinese tech. Here are some of the spicier takes and helpful articles to get up to speed:

  • Key takeaways from TikTok hearing in Congress – and the uncertain road ahead – Kari Paul and Johana Bhuiyan, The Guardian 
  • What to Know About the TikTok Security Concerns – Billy Perrigo, Time
  • America’s online privacy problems are much bigger than TikTok – Will Oremus, Washington Post
  • There’s a Problem With Banning TikTok. It’s Called the First Amendment– Jameel Jaffer (Executive Director of the Knight First Amendment Institute), NYT Opinion

What I learned this week

AI is able to persuade people to change their minds about hot-button political issues like an assault weapon ban and paid parental leave, according to a study by a team at Stanford’s Polarization and Social Change Lab. The researchers compared people’s political opinions on a topic before and after reading an AI-generated argument, and found that these arguments can be as effective as human-written ones in persuading the readers: “AI ranked consistently as more factual and logical, less angry, and less reliant upon storytelling as a persuasive technique.” 

The teams point to concerns about the use of generative AI in a political context, such as in lobbying or online discourse. (For more on the use of generative AI in politics, do please read this recent piece by Nathan Sanders and Bruce Schneier.)

Article link: https://www-technologyreview-com.cdn.ampproject.org/c/s/www.technologyreview.com/2023/03/27/1070285/early-guide-policymaking-generative-ai-gpt4/amp/

Share this:

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
Like Loading...

Related

Posts navigation

← Equality – Engine of Democracy; Inequality Engine of Authoritarianism
The Trust Crisis HBR →
  • Search site

  • Follow healthcarereimagined on WordPress.com
  • Recent Posts

    • WHAT A QUBIT IS AND WHAT IT IS NOT. 01/25/2026
    • Governance Before Crisis We still have time to get this right. 01/21/2026
    • On the Eve of Davos: We’re Just Arguing About the Wrong Thing 01/18/2026
    • Are AI Companies Actually Ready to Play God? – RAND 01/17/2026
    • ChatGPT Health Is a Terrible Idea 01/09/2026
    • Choose the human path for AI – MIT Sloan 01/09/2026
    • Why AI predictions are so hard – MIT Technology Review 01/07/2026
    • Will AI make us crazy? – Bulletin of the Atomic Scientists 01/04/2026
    • Decisions about AI will last decades. Researchers need better frameworks – Bulletin of the Atomic Scientists 12/29/2025
    • Quantum computing reality check: What business needs to know now – MIT Sloan 12/29/2025
  • Categories

    • Accountable Care Organizations
    • ACOs
    • AHRQ
    • American Board of Internal Medicine
    • Big Data
    • Blue Button
    • Board Certification
    • Cancer Treatment
    • Data Science
    • Digital Services Playbook
    • DoD
    • EHR Interoperability
    • EHR Usability
    • Emergency Medicine
    • FDA
    • FDASIA
    • GAO Reports
    • Genetic Data
    • Genetic Research
    • Genomic Data
    • Global Standards
    • Health Care Costs
    • Health Care Economics
    • Health IT adoption
    • Health Outcomes
    • Healthcare Delivery
    • Healthcare Informatics
    • Healthcare Outcomes
    • Healthcare Security
    • Helathcare Delivery
    • HHS
    • HIPAA
    • ICD-10
    • Innovation
    • Integrated Electronic Health Records
    • IT Acquisition
    • JASONS
    • Lab Report Access
    • Military Health System Reform
    • Mobile Health
    • Mobile Healthcare
    • National Health IT System
    • NSF
    • ONC Reports to Congress
    • Oncology
    • Open Data
    • Patient Centered Medical Home
    • Patient Portals
    • PCMH
    • Precision Medicine
    • Primary Care
    • Public Health
    • Quadruple Aim
    • Quality Measures
    • Rehab Medicine
    • TechFAR Handbook
    • Triple Aim
    • U.S. Air Force Medicine
    • U.S. Army
    • U.S. Army Medicine
    • U.S. Navy Medicine
    • U.S. Surgeon General
    • Uncategorized
    • Value-based Care
    • Veterans Affairs
    • Warrior Transistion Units
    • XPRIZE
  • Archives

    • January 2026 (8)
    • December 2025 (11)
    • November 2025 (9)
    • October 2025 (10)
    • September 2025 (4)
    • August 2025 (7)
    • July 2025 (2)
    • June 2025 (9)
    • May 2025 (4)
    • April 2025 (11)
    • March 2025 (11)
    • February 2025 (10)
    • January 2025 (12)
    • December 2024 (12)
    • November 2024 (7)
    • October 2024 (5)
    • September 2024 (9)
    • August 2024 (10)
    • July 2024 (13)
    • June 2024 (18)
    • May 2024 (10)
    • April 2024 (19)
    • March 2024 (35)
    • February 2024 (23)
    • January 2024 (16)
    • December 2023 (22)
    • November 2023 (38)
    • October 2023 (24)
    • September 2023 (24)
    • August 2023 (34)
    • July 2023 (33)
    • June 2023 (30)
    • May 2023 (35)
    • April 2023 (30)
    • March 2023 (30)
    • February 2023 (15)
    • January 2023 (17)
    • December 2022 (10)
    • November 2022 (7)
    • October 2022 (22)
    • September 2022 (16)
    • August 2022 (33)
    • July 2022 (28)
    • June 2022 (42)
    • May 2022 (53)
    • April 2022 (35)
    • March 2022 (37)
    • February 2022 (21)
    • January 2022 (28)
    • December 2021 (23)
    • November 2021 (12)
    • October 2021 (10)
    • September 2021 (4)
    • August 2021 (4)
    • July 2021 (4)
    • May 2021 (3)
    • April 2021 (1)
    • March 2021 (2)
    • February 2021 (1)
    • January 2021 (4)
    • December 2020 (7)
    • November 2020 (2)
    • October 2020 (4)
    • September 2020 (7)
    • August 2020 (11)
    • July 2020 (3)
    • June 2020 (5)
    • April 2020 (3)
    • March 2020 (1)
    • February 2020 (1)
    • January 2020 (2)
    • December 2019 (2)
    • November 2019 (1)
    • September 2019 (4)
    • August 2019 (3)
    • July 2019 (5)
    • June 2019 (10)
    • May 2019 (8)
    • April 2019 (6)
    • March 2019 (7)
    • February 2019 (17)
    • January 2019 (14)
    • December 2018 (10)
    • November 2018 (20)
    • October 2018 (14)
    • September 2018 (27)
    • August 2018 (19)
    • July 2018 (16)
    • June 2018 (18)
    • May 2018 (28)
    • April 2018 (3)
    • March 2018 (11)
    • February 2018 (5)
    • January 2018 (10)
    • December 2017 (20)
    • November 2017 (30)
    • October 2017 (33)
    • September 2017 (11)
    • August 2017 (13)
    • July 2017 (9)
    • June 2017 (8)
    • May 2017 (9)
    • April 2017 (4)
    • March 2017 (12)
    • December 2016 (3)
    • September 2016 (4)
    • August 2016 (1)
    • July 2016 (7)
    • June 2016 (7)
    • April 2016 (4)
    • March 2016 (7)
    • February 2016 (1)
    • January 2016 (3)
    • November 2015 (3)
    • October 2015 (2)
    • September 2015 (9)
    • August 2015 (6)
    • June 2015 (5)
    • May 2015 (6)
    • April 2015 (3)
    • March 2015 (16)
    • February 2015 (10)
    • January 2015 (16)
    • December 2014 (9)
    • November 2014 (7)
    • October 2014 (21)
    • September 2014 (8)
    • August 2014 (9)
    • July 2014 (7)
    • June 2014 (5)
    • May 2014 (8)
    • April 2014 (19)
    • March 2014 (8)
    • February 2014 (9)
    • January 2014 (31)
    • December 2013 (23)
    • November 2013 (48)
    • October 2013 (25)
  • Tags

    Business Defense Department Department of Veterans Affairs EHealth EHR Electronic health record Food and Drug Administration Health Health informatics Health Information Exchange Health information technology Health system HIE Hospital IBM Mayo Clinic Medicare Medicine Military Health System Patient Patient portal Patient Protection and Affordable Care Act United States United States Department of Defense United States Department of Veterans Affairs
  • Upcoming Events

Blog at WordPress.com.
  • Reblog
  • Subscribe Subscribed
    • healthcarereimagined
    • Join 153 other subscribers
    • Already have a WordPress.com account? Log in now.
    • healthcarereimagined
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar
 

Loading Comments...
 

    %d